Montes Archimedes Acquisition (ROIV)
(Real Time Quote from BATS)
$10.76 USD
-0.14 (-1.28%)
Updated Apr 25, 2024 10:16 AM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 27% (69 out of 251)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.18 | NA | NA |
Current Quarter Estimate | NA | NA | NA |
Year Ago Quarter Estimate | NA | NA | NA |
Next Quarter Estimate | NA | NA | NA |
Next Year Estimate | NA | NA | NA |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 31.65 | 12.90 | 5.37 |
Next Year | 0.93 | 8.30 | 11.11 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 19.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | NA |
Price/Book (MRQ) | NA | NA |
Price/Cash Flow (MRFY) | NA | NA |
Dividend Yield | NA | NA |
Net Profit Margin (TTM) | NA | NA |
Return on Equity (TTM) | NA | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.